The World Health Organization (WHO)’s Global TB Programme in collaboration with the Republic of Korea Centers for Disease Control and Prevention and the International Tuberculosis Research Center of Korea (ITRC) conducted a Global consultation meeting on the programmatic management of latent tuberculosis infection on April 27-28, 2016 in Seoul, Republic of Korea.

In advance of World TB Day, to be observed on March 24, the World Health Organization (WHO) is calling on countries and partners to "Unite to End Tuberculosis".

The World Health Organization (WHO)’s Global TB Program is establishing a Civil Society Task Force on TB (CSTF) to enhance the engagement of communities, non-governmental and other civil society organizations in the implementation of the End TB Strategy.

A new WHO report reviews progress and challenges in the global response to HIV, tuberculosis, malaria, hepatitis and neglected tropical diseases against the Millennium Development Goals, and identifies the strategies and approaches needed to accelerate progress during the new development era.

TB/HIV and community engagement unit of the World Health Organization (WHO)’s Global TB Programme coordinates the Department’s work on TB/HIV and the delivery of integrated community based TB activities through both national TB programmes and the engagement of non-governmental (NGO) and other civil society organisations (CSO) to integrate TB into their community-based work in HIV, maternal and child health, primary health care and other sectors such as education, agriculture and livelihood development programmes.

WHO consolidated guidelines: Integrating collaborative TB and HIV services within a comprehensive package of care for people who inject drugs

Seoul, Republic of Korea, 27 – 28 April 2016

Click here to access a list of training courses on tuberculosis offered by WHO Collaborating Centers and partners in the European Region.

The World Health Organization report presents the latest data and in-depth analysis for the key areas outlined in the health Sustainable Development Goals, including tuberculosis.

The World Health Organization (WHO) has evaluated a new diagnostic test - Alere DetermineTM - a urine lateral flow lipoarabinomannan assay (LF-LAM,) to determine its suitability for use in the screening or diagnosis of tuberculosis disease.